Yahoo Buys Tumblr f...
Health Care: Health Services
Derma Sciences Inc. (DSCI: NASDAQ)
$13.94 -0.35 | -2.45%
05/20/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 72.65M | 62.63M | 56.47M | 48.53M |
| Cost of Sales | 44.21M | 41.58M | 37.25M | 31.13M |
| Gross Operating Profit | 28.44M | 21.05M | 19.22M | 17.40M |
| Selling, General, and Administrative Expenses | 32.49M | 21.17M | 17.91M | 15.14M |
| Research & Development | 7.12M | 1.06M | 292.66K | 399.56K |
| Operating Income before D & A (EBITDA) | -11.17M | -1.18M | 1.03M | 1.87M |
| Depreciation & Amortization | 3.30M | 2.64M | 2.70M | 2.34M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 47.60K | -188.78K | 226.14K | 244.60K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -14.42M | -4.01M | -1.44M | -232.48K |
| Interest Expense | 20.87K | 263.06K | 580.62K | 842.13K |
| Pre-Tax Income | -14.44M | -4.27M | -2.02M | -1.07M |
| Income Taxes | -2.37M | 69.54K | 423.96K | 68.66K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -12.07M | -4.34M | -2.45M | -1.14M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -12.07M | -4.34M | -2.45M | -1.14M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -12.07M | -4.34M | -2.45M | -1.14M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-12.07M | -4.34M | -2.45M | -1.14M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -12.07M | -4.34M | -2.45M | -1.14M |
| Basic EPS from Continuing Ops. | -0.97 | -0.49 | -0.39 | -0.23 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.97 | -0.49 | -0.39 | -0.23 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.97 | -0.49 | -0.39 | -0.23 |
| Basic Normalized Net Income/Share | -0.97 | -0.49 | -0.39 | -0.23 |
| EPS fr Continuing Ops. | -0.97 | -0.49 | -0.39 | -0.23 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.97 | -0.49 | -0.39 | -0.23 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.97 | -0.49 | -0.39 | -0.23 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.97 | -0.49 | -0.39 | -0.23 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DSCI
- Portfolio NameUser Type
- UserMedical devices M&A
- Contributor3 Small-Cap Stocks on Insid...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- UserTest Drive
- Contributor10 Cheap Biotech Stocks Tha...
- Contributor5 Health Care Stocks With U...
- ContributorBarron's Insider Purchases ...
- UserPINOCH
Latest DSCI Headlines from TheStreet
- DSCI January 2014 Options Begin Trading 05.20.13 | 03:05 pm
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- 3 Small-Cap Stocks on Insiders' Radar 11.18.11 | 01:11 pm
- Insiders Trading BBBY, ENTG, DSCI, CHKM 10.20.11 | 10:10 am
- 11 Biotech Stocks Loved or Hated by Hedge Funds 08.17.11 | 06:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Insiders Trading NS, TZOO, DSCI, CRR 05.28.11 | 03:05 pm
- Biotech Stock Mailbag: Fibrocell Science 05.27.11 | 06:05 am
- Derma Stock Soars (DSCI) 05.25.11 | 10:05 am
Press Releases for DSCI
- Derma Sciences Announces Timing For Fourth Quarter Conference Call And 2012 Form 10-K Filing - Business Wire 03.15.13 | 04:03 pm
- Derma Sciences To Present At The 25th Annual ROTH Conference - Business Wire 03.14.13 | 12:03 pm
- Derma Sciences Initiates Enrollment In DSC127 Phase 3 Trial For Healing Diabetic Foot Ulcers - Business Wire 02.06.13 | 08:02 am
- Derma Sciences Closes $36.4 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment - Business Wire 12.11.12 | 05:12 pm
- Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock - Business Wire 12.06.12 | 09:12 am
- Derma Sciences Announces Commencement Of Public Offering Of Common Stock - Business Wire 12.05.12 | 04:12 pm
- Derma Sciences To Present At Two Upcoming Conferences - Business Wire 11.30.12 | 02:11 pm
- Derma Sciences To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 08:11 am
- Derma Sciences To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 10:11 am
- Derma Sciences Reports Third Quarter 2012 Financial Results - Business Wire 11.12.12 | 07:11 am
Partner Headlines for DSCI
- Pre-Market Earnings Report for April 1, 2013 : CALM, DSCI - NASDAQ 03.28.13 | 08:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.04.12 | 09:12 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.29.12 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.20.12 | 09:11 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 09.12.11 | 09:09 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.31.11 | 09:03 am
